about
De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneysNMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavityNovel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeMolecular cloning and characterization of the gene encoding N'-[(5'-phosphoribosyl)-formimino]-5-aminoimidazole-4-carboxamide ribonucleotide (BBM II) isomerase from Arabidopsis thaliana.Differential resuscitative effect of pyruvate and its analogues on VBNC (viable but non-culturable) Salmonella.Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5'-flanking region and the AP-2 element in the untranslated exon 1.Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.Suppression of Very Early Stage Of Adipogenesis by Baicalein, a Plant-Derived Flavonoid through Reduced Akt-C/EBPα-GLUT4 Signaling-Mediated Glucose Uptake in 3T3-L1 AdipocytesDrug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier.Zebrafish and chicken lipocalin-type prostaglandin D synthase homologues: Conservation of mammalian gene structure and binding ability for lipophilic molecules, and difference in expression profile and enzyme activity.Activation of early phase of adipogenesis through Krüppel-like factor KLF9-mediated, enhanced expression of CCAAT/enhancer-binding protein β in 3T3-L1 cells.Differential expression and function of alternative splicing variants of human liver X receptor α.Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin-proteasome system in response to intracellular calcium levelPrevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells.Adipokine ganglioside GM2 activator protein stimulates insulin secretion.Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase.Forkhead transcription factor Foxa1 is a novel target gene of C/EBPβ and suppresses the early phase of adipogenesis.Increased production of lipocalin-type prostaglandin D synthase in leptomeningeal cells through contact with astrocytes.Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of notch-HES signaling and enhancement of AP-2 beta function in brain-derived TE671 cells.Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.Influence of the culture medium on the production of nitric oxide and expression of inducible nitric oxide synthase by activated macrophages in vitro.Prostaglandins as PPARγ Modulators in Adipogenesis.The P-OLE1 gene of Pichia angusta encodes a delta 9-fatty acid desaturase and complements the ole1 mutation of Saccharomyces cerevisiae.An Arabidopsis cDNA encoding a bifunctional glutamine amidotransferase/cyclase suppresses the histidine auxotrophy of a Saccharomyces cerevisiae his7 mutant.Niacin promotes adipogenesis by reducing production of anti-adipogenic PGF2α through suppression of C/EBPβ-activated COX-2 expression.Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells.Prostaglandin D2 enhances lipid accumulation through suppression of lipolysis via DP2 (CRTH2) receptors in adipocytes.Transcriptional regulation in adipogenesis through PPARγ-dependent and -independent mechanisms by prostaglandins.Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.A Limonoid Kihadanin B from Immature Citrus unshiu Peels Suppresses Adipogenesis through Repression of the Akt-FOXO1-PPARγ Axis in Adipocytes.Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes.Termination mechanism of CREB-dependent activation of COX-2 expression in early phase of adipogenesis.Triiodothyronine enhances accumulation of intracellular lipids in adipocytes through thyroid hormone receptor α via direct and indirect mechanisms.Fisetin Suppresses Lipid Accumulation in Mouse Adipocytic 3T3-L1 Cells by Repressing GLUT4-Mediated Glucose Uptake through Inhibition of mTOR-C/EBPα Signaling.A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c.Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ¹²-PGJ₂ acting through PPARγ-dependent and independent pathways.Prostaglandin F(2alpha) suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells.Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
P50
Q24312883-699C077C-7776-4EE9-BF77-412CCB9C8B2CQ28506812-F6220E97-5562-41D1-8CF5-0E25B6E9D66FQ28586698-C451A27C-6024-49C4-B289-7930945A4B0BQ32017065-DD8535BE-DA4E-44BF-BC36-4EAC6105E0EBQ33805656-870B5A11-66B0-4966-9664-B9A32543B80BQ33918650-71D2BCE7-D86D-449D-840A-E54EBAA2DE75Q34412709-676F37A3-9605-4CBD-A1D3-67285D6E982BQ34976601-22F6CA65-3D4A-4815-8DA4-AC230B07FF77Q36145116-E8C972A0-7900-4199-B700-87F42F1BA6A8Q36717154-CFE3A130-77A4-4BED-9379-3A9DD827A234Q38314235-7966A0D6-7EFC-4DEF-B501-E2F4D9513EE1Q39063890-39437F36-6495-456C-9BFB-18F0671D4A96Q39383621-9FEB2667-F0C9-4958-897E-BF45C4F5615EQ39448819-C8258039-7962-45A9-A0CB-135EAACFA70EQ39449759-152EE5ED-CD09-4B69-9C2E-C0F877B0F016Q39464710-76BCEC45-C5A7-42C4-9B2B-DE1FCEBF51F8Q39501911-6292B448-D695-43B3-A68A-B39D1D226996Q39615733-DBDD4988-EBBC-4E10-A4D1-59877DC40A07Q39618756-ED2C58F6-7D7D-40BD-A21B-32D842C74677Q40096991-14590F4B-1282-4398-B5F6-1123570B40B7Q40451710-6764D337-2CAD-4861-B890-0F5773A25598Q40797404-431B8162-41D7-4783-9832-FBA7B0B01490Q41683284-E25CDC65-5FC0-48FE-9260-EC7A47CCCF67Q41873873-008735B3-2DAC-446B-B3B3-90BD1E8366F3Q42649644-CBEF2E7A-813F-4129-A08B-C3E0D2C58850Q42680318-D68D7258-B325-4475-8163-D674D5FFCFFFQ42757393-005898F5-3798-4BFB-B28C-3C3969C48CDCQ42798033-95071B97-1BCF-4359-8853-894ACE313DD8Q42799793-269AD72E-B10E-48B2-9973-05AC9DC6A6B0Q42801239-50A4BE47-FC4F-442C-8944-E799297EF8EBQ42803088-9364538A-4E25-4ED7-B409-AAAE75C34FD1Q42804692-A6B0635B-DC6E-4A34-851E-075FF399A670Q42806968-14C42D7E-1076-4EB0-9CD6-E820A56BE5BAQ42808613-5A528B3D-65B7-4FF0-84DE-015912D4DDCAQ42811139-33568811-6B21-4627-BDA1-86E5663DEC49Q42827560-3694D928-E51F-4666-95A4-8BA2981A46A8Q42829127-FC609682-1232-432C-9F71-F92C4EC0978AQ42834186-778C1D01-6FD7-49CA-B42F-AA2E611630BCQ42987178-6AB0A22D-CE6E-4291-97DA-F6D961A0E1B6Q43171502-8051D8D8-3470-4463-B144-04BFB3BC20EA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ko Fujimori
@ast
Ko Fujimori
@en
Ko Fujimori
@es
Ko Fujimori
@nl
Ko Fujimori
@sl
type
label
Ko Fujimori
@ast
Ko Fujimori
@en
Ko Fujimori
@es
Ko Fujimori
@nl
Ko Fujimori
@sl
prefLabel
Ko Fujimori
@ast
Ko Fujimori
@en
Ko Fujimori
@es
Ko Fujimori
@nl
Ko Fujimori
@sl
P106
P1153
7102225898
P21
P31
P496
0000-0002-2506-0769
P569
2000-01-01T00:00:00Z